Published in Telemedicine Law Weekly, January 13th, 2007
This trend article about McGill University, Canada, is an immediate alert from NewsRx to identify developing directions of research.
Study 1: New research, "Protein tyrosine kinase signaling diversity and susceptibility to targeted kinase inhibitors," is the subject of a report. According to recent research published in the journal Biomedicine and Pharmacotherapy, "Protein kinases, including tyrosine kinases, are one of the largest classes of proteins implicated in cancer development and progression. Recent discovery of selective therapies targeting tyrosine kinase receptor signaling...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Law Weekly